Table 2.
Effects of i.c.v. aCSF on basal LSNA, MAP and HR (n = 4)
| Control | i.c.v. aCSF for 1 h | i.c.v. aCSF for 2 h | |
|---|---|---|---|
| Basal LSNA (% of control) | 100 ± 0 | 94 ± 5 | 93 ± 10 |
| Basal MAP (mmHg) | 104 ± 6 | 102 ± 7 | 103 ± 8 |
| Basal HR (b.p.m.) | 334 ± 8 | 346 ± 8 | 342 ± 7 |
| LSNA max. (% of control) | 196 ± 8 | 187 ± 4 | 206 ± 15 |
| LSNA min. (% of control) | 61 ± 8 | 62 ± 10 | 63 ± 10 |
| LSNA BP50 (mmHg) | 85 ± 5 | 87 ± 6 | 86 ± 9 |
| LSNA width (mmHg) | 10.8 ± 1.7 | 11.0 ± 2.9 | 12.1 ± 2.5 |
| LSNA range (% of control) | 135 ± 13 | 126 ± 11 | 144 ± 16 |
| LSNA gain (% of control/mmHg) | 3.4 ± 0.6 | 3.3 ± 0.6 | 3.3 ± 0.7 |
| HR max (b.p.m.) | 436 ± 6 | 442 ± 3 | 438 ± 8 |
| HR min (b.p.m.) | 305 ± 15 | 304 ± 17 | 301 ± 14 |
| HR BP50 (mmHg) | 120 ± 6 | 119 ± 6 | 124 ± 5 |
| HR width (mmHg) | 8.2 ± 0.5 | 8.3 ± 0.7 | 8.5 ± 0.4 |
| HR range (b.p.m.) | 132 ± 19 | 138 ± 18 | 137 ± 15 |
| HR gain (b.p.m. mmHg–1) | 4.0 ± 0.5 | 4.2 ± 0.3 | 4.0 ± 0.4 |